50jili site
A former teacher has warned that the internet may create a societal divide between those who use it frequently and those who do not. Mike Bonitatibus, 38, who now works as a sales professional in Kennett Square, Pennsylvania, spent 14 years as a health and physical education teacher. His experience in the classroom inspired him to create a video that has since gone viral, amassing more than 627,000 views. In the video, Bonitatibus said, "We are about to see a split in society, and I don't mean anything political." He went on to discuss a growing gap between children raised with unfiltered internet access from birth and those whose screen time was carefully moderated by their parents. He told Newsweek : "I regularly encountered students engrossed in their devices. I didn't feel like a teacher anymore because kids were always more interested in being on a device than talking or learning." He added: "More recently, I noticed how many kids had iPads in social settings like restaurants and events. As I considered leaving the teaching profession, I became increasingly aware of the larger trend; many educators across the nation were facing similar challenges. "A noticeable lack of discipline and consequences in schools, combined with many students being emotionally unregulated and unfocused, were significant concerns." As a teacher, Bonitatibus was made aware of "troubling stories" from students who were exposed to inappropriate content on social media. He said devices made teaching challenging. "Students often struggled to concentrate and displayed a resistance to authority," he added. "This marked shift in behavior not only impacted their learning but also raised alarm bells for me regarding their social development." How Do Phones Affect Development? A U.S. survey shared by Statista found that tablet usage among children rose from 68 percent in March 2020 to 81 percent in April 2021—driven by the COVID-19 pandemic, which necessitated remote learning and online socializing. By 2021, 71 percent of children under 11 were also using smartphones. Bonitatibus said: "In my observation, children who grow up with moderated internet access tend to develop stronger social skills, better discipline, and the ability to remain focused on tasks. "In contrast, those raised with unrestricted access to devices often find social interactions difficult and may exhibit more defiance and disrespect. It was concerning to see previously respectful students conforming to a culture of disengagement and disrespect toward authority figures." Who Is More Likely to Face Challenges in the Future? Bonitatibus said both groups would face challenges. However, "iPad kids" may have "more significant difficulties." "With many children now experiencing unfiltered internet access, families with established boundaries may struggle to connect with those who lack them," he added. He said iPad kids may struggle to navigate real-world situations, "leading to an inflated sense of entitlement due to the absence of boundaries." The former teacher continued: "My overall message in the video is that there is a solution: emotional intelligence. We need more and more adults to know and understand their emotions better so they can better handle the emotional issues going on. "If more parents become aware of the dangers of unfiltered internet and seek out help in therapy or emotional intelligence coaching, it could go a long way." Studies suggest that increased screen time may hinder development: Greater screen time at 24 months predicts poorer developmental test performance at 36 months, and higher screen time at 36 months correlates with lower scores at 60 months. A Balanced Approach to Technology in Parenting Parenting coach Liat Hughes Joshi hopes technology isn't demonized, as it's an increasing part of our lives. The author of six parenting books, including How to Unplug Your Child , told Newsweek that internet access could be beneficial. She said: "We need to be having more nuanced conversations, not just about quantity of tech use but quality. Educational activities such as learning to code or picking up a foreign language for example, or playing chess online. Carefully used, the internet can also be a place to find emotional support and advice if they're experiencing a difficult situation, such as being bullied. "Clearly, we're all pretty well-versed on the myriad bad things the internet can introduce into their lives, but by having a more balanced conversation with our kids, which acknowledges that it's not all bad, they're actually more likely to listen to us and our advice around safer internet usage." TikTok Reacts Bonitatibus' video has received more than 4,000 comments, with teachers weighing in with their experiences. "It's really obvious in my classroom now. The tech kids have no depth, empathy, imagination, or motivation. It's sad really," one viewer wrote. "As a high school teacher, I already see it in my classes. I could pretty much divide my class up by those who've had a lot of screen time versus those who haven't," another added. Bonitatibus asked the user, "How would you describe the kids on each side of the room?" She responded: "Their attention spans, ability to problem solve, and how they spend their unstructured time. They are either glued to a device or find other ways to spend their time ( games, puzzles , talking to peers)." If you have a family dilemma, let us know via life@newsweek.com. We can ask experts for advice, and your story could be featured on Newsweek .
Meta to build $10 billion AI data center in Louisiana as Elon Musk expands his Tennessee AI facility
The Ensign Group, Inc. ( NASDAQ:ENSG – Get Free Report ) declared a quarterly dividend on Friday, December 13th, Wall Street Journal reports. Stockholders of record on Tuesday, December 31st will be paid a dividend of 0.0625 per share on Friday, January 31st. This represents a $0.25 annualized dividend and a dividend yield of 0.19%. The ex-dividend date of this dividend is Tuesday, December 31st. This is an increase from The Ensign Group’s previous quarterly dividend of $0.06. The Ensign Group has increased its dividend payment by an average of 4.7% annually over the last three years and has raised its dividend every year for the last 18 years. The Ensign Group has a payout ratio of 4.1% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect The Ensign Group to earn $5.58 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 4.5%. The Ensign Group Price Performance Shares of NASDAQ ENSG opened at $133.98 on Friday. The Ensign Group has a 52 week low of $110.71 and a 52 week high of $158.45. The business’s 50 day moving average price is $145.21 and its 200 day moving average price is $141.83. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.08. The firm has a market cap of $7.68 billion, a P/E ratio of 32.44, a P/E/G ratio of 1.90 and a beta of 0.92. Insider Transactions at The Ensign Group In other news, CEO Barry Port sold 2,000 shares of The Ensign Group stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $155.00, for a total value of $310,000.00. Following the sale, the chief executive officer now owns 53,716 shares in the company, valued at $8,325,980. This trade represents a 3.59 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link . Corporate insiders own 3.90% of the company’s stock. Analysts Set New Price Targets ENSG has been the subject of a number of recent research reports. Royal Bank of Canada lifted their price objective on The Ensign Group from $167.00 to $172.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Truist Financial boosted their price target on The Ensign Group from $160.00 to $170.00 and gave the company a “hold” rating in a report on Monday, October 28th. Stephens raised their price objective on shares of The Ensign Group from $163.00 to $167.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Oppenheimer boosted their target price on shares of The Ensign Group from $165.00 to $168.00 and gave the company an “outperform” rating in a research note on Friday, October 25th. Finally, UBS Group began coverage on shares of The Ensign Group in a research report on Thursday, November 21st. They set a “buy” rating and a $175.00 price target on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, The Ensign Group has a consensus rating of “Moderate Buy” and an average target price of $164.33. Get Our Latest Analysis on ENSG About The Ensign Group ( Get Free Report ) The Ensign Group, Inc provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Further Reading Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter .None
OpenAI CEO Sam Altman expressed confidence Wednesday that Elon Musk would not use his proximity to Donald Trump to harm business rivals, calling such actions "profoundly un-American." Speaking at the New York Times DealBook conference, Altman addressed concerns about Musk's announced role heading a new Department of Government Efficiency in the incoming Donald Trump administration, and whether he might use it to favor his own companies. "I may turn out to be wrong, but I believe pretty strongly that Elon will do the right thing," Altman said. "It would be profoundly un-American to use political power to hurt your competitors and advantage your own businesses." Even if there are "lots of things not to like about him... it would go so deeply against the values I believe he holds very dear to himself that I'm not that worried about it." Musk, an OpenAI co-founder who later departed the company, is currently suing Altman's firm and Microsoft, claiming they shifted from the project's original nonprofit mission. He has since launched xAI, reportedly valued at $50 billion, making it one of the world's most valuable startups. Altman said that the court battle was "tremendously sad" and that he once saw Musk as "a mega hero." Musk became a close ally of Trump during his campaign, spending over $100 million to boost his presidential bid and joining him at rallies. Since the election victory, he has been a frequent presence in the Trump transition and was reportedly on the line when Google CEO Sundar Pichai called the president-elect to congratulate him on winning the election. The tycoon's businesses have deep connections with governments -- both in the United States and elsewhere -- and his new position has raised concerns about conflict of interest. During the interview, Altman also lowered expectations for the importance of OpenAI's models achieving artificial general intelligence (AGI), a benchmark of human-level intelligence the company has long set as the goal for its technology. "My guess is we will hit AGI sooner than most people in the world think, and it will matter much less," he said. "A lot of the safety concerns that we and others expressed actually don't come at the AGI moment... AGI can get built. The world goes on mostly the same way," he said. arp/ahaBy MARC LEVY HARRISBURG, Pa. (AP) — Democratic Sen. Bob Casey of Pennsylvania conceded his reelection bid to Republican David McCormick on Thursday, as a statewide recount showed no signs of closing the gap and his campaign suffered repeated blows in court in its effort to get potentially favorable ballots counted. Casey’s concession comes more than two weeks after Election Day, as a grindingly slow ballot-counting process became a spectacle of hours-long election board meetings, social media outrage, lawsuits and accusations that some county officials were openly flouting the law. Republicans had been claiming that Democrats were trying to steal McCormick’s seat by counting “illegal votes.” Casey’s campaign had accused of Republicans of trying to block enough votes to prevent him from pulling ahead and winning. In a statement, Casey said he had just called McCormick to congratulate him. “As the first count of ballots is completed, Pennsylvanians can move forward with the knowledge that their voices were heard, whether their vote was the first to be counted or the last,” Casey said. The Associated Press called the race for McCormick on Nov. 7, concluding that not enough ballots remained to be counted in areas Casey was winning for him to take the lead. As of Thursday, McCormick led by about 16,000 votes out of almost 7 million ballots counted. That was well within the 0.5% margin threshold to trigger an automatic statewide recount under Pennsylvania law. But no election official expected a recount to change more than a couple hundred votes or so, and Pennsylvania’s highest court dealt him a blow when it refused entreaties to allow counties to count mail-in ballots that lacked a correct handwritten date on the return envelope. Republicans will have a 53-47 majority next year in the U.S. Senate. Follow Marc Levy at twitter.com/timelywriter
NEW YORK , Dec. 4, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global precision medicine market size is estimated to grow by USD 66.2 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 12.34% during the forecast period. Growing prevalence of chronic diseases is driving market growth, with a trend towards growing use of artificial intelligence (AI) and machine learning (ML) in precision medicine. However, data privacy and security issues associated with precision medicine poses a challenge. Key market players include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocrates Life Sciences AG, Bristol Myers Squibb Co., Catalent Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., IQVIA Holdings Inc., Johnson and Johnson Services Inc., Lonza Group Ltd., Merck and Co. Inc., Novartis AG, Parexel International Corp., Pfizer Inc., QIAGEN NV, Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Thermo Fisher Scientific Inc.. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View Free Sample Report PDF Key Market Trends Fueling Growth The Precision Medicine Market is experiencing significant growth due to the increasing focus on personalized treatment for various diseases. This approach takes into account environmental, genetic, and behavioral variability to understand illness susceptibility and disease progression. Precision medicine is revolutionizing the way we diagnose and treat conditions such as chromosomal abnormalities in fetuses, cancer, chronic diseases, CNS Disorders including Alzheimer's disease, Epilepsy, and Multiple Sclerosis. Companies like Cleveland Clinic are leading the way with companion diagnostics and genetic testing, using genes and proteins to develop personalized treatment drugs. Technologies like single nucleotide polymorphism detection, microarray/biochips, and genome sequencing are key tools in this field. The biopharmaceutical arena is embracing precision medicine, with Orchard Therapeutics being a notable player. However, reimbursement policies, calculation methodology, and regulatory challenges remain. The market presents numerous opportunities for targeted gene therapy, pharmacogenomics, and personalized therapeutics. Despite these challenges, positive results are driving commercialization. Gene sequencing and genetics and genomics research are paving the way for precision medicine access and wider adoption, even in developing regions. Rare genetic disorders and other rare diseases are also benefiting from this therapeutic approach. The future of healthcare lies in the development and commercialization of precision medicine treatments. Precision medicine is experiencing significant advancements with the integration of Artificial Intelligence (AI) and Machine Learning (ML) technologies. These technologies facilitate the analysis of extensive patient data, leading to more targeted and personalized treatments. In the realm of diagnosis, AI and ML algorithms enhance clinicians' capabilities, enabling risk prediction and therapy planning. Drug discovery also benefits from these technologies, as AI and ML can identify potential drug targets and predict new drugs' efficacy, expediting the drug development process. Insights on how AI is driving innovation, efficiency, and market growth- Request Sample! The Precision Medicine Market is experiencing significant growth due to the increasing understanding of the role of genetic, environmental, and behavioral variability in illness susceptibility and disease progression. This market encompasses prescription medicines for chromosomal abnormalities like Down Syndrome, cancer, chronic diseases such as Alzheimer's disease, epilepsy, and multiple sclerosis. Companies like Cleveland Clinic and Orchard Therapeutics are leading the way with companion diagnostics, genetic testing, and personalized therapeutics. However, challenges include environmental variability, genetic variability, and behavioral variability, as well as reimbursement policies, calculation methodology, and regulatory hurdles. Market opportunities lie in targeted gene therapy, genome sequencing, and personalized treatment choices based on molecular profiles and clinical characteristics. Biopharmaceutical players in the oncology application are investing in drug discovery technology, pharmacogenomics, pharmacokinetics, and pharmacodynamics to develop and commercialize precision medicine therapeutics. Despite these challenges, the potential for positive results and wider adoption, especially for rare genetic disorders and other rare diseases, makes this a promising area for the biopharmaceutical arena. The precision medicine market faces a significant challenge in ensuring data privacy and security. With the collection and analysis of large patient datasets, including genetic and molecular information, medical history, and lifestyle factors, comes the responsibility to protect this sensitive data from unauthorized access and misuse. Precision medicine data is highly valuable and a potential target for cyberattacks and data breaches. To mitigate this risk, researchers and healthcare providers must implement security measures. These measures include encryption, firewalls, and other security technologies to safeguard data during storage and transmission. Ensuring data privacy and security is crucial to maintain patient trust and confidence in the precision medicine industry. Insights into how AI is reshaping industries and driving growth- Download a Sample Report Segment Overview This precision medicine market report extensively covers market segmentation by 1.1 Oncology 1.2 CNS 1.3 Respiratory 1.4 Immunology 1.5 Others 2.1 Bioinformatics 2.2 Gene sequencing 2.3 Drug discovery 2.4 Precision molecular diagnostic 2.5 Big data analytics 3.1 North America 3.2 Europe 3.3 Asia 3.4 Rest of World (ROW) 1.1 Oncology- Precision medicine is revolutionizing the field of oncology by enabling doctors to create customized treatment plans based on a patient's unique genetic and biomarker data. In oncology, this approach allows for the identification of high-risk individuals, early cancer detection, precise cancer type identification, effective treatment selection, and treatment efficacy analysis. Two notable examples of precision medicine in oncology are molecularly targeted therapies and immunotherapy. Molecularly targeted therapies are drugs designed to inhibit specific molecular pathways driving cancer growth, minimizing damage to healthy cells. Immunotherapy harnesses the patient's immune system to fight cancer by targeting molecular markers on cancer cells, leading to better treatment outcomes and fewer side effects. Precision medicine also plays a crucial role in identifying individuals at higher risk for certain cancers, such as breast and ovarian cancer, by analyzing genetic data for mutations like BRCA1 and BRCA2. The growing adoption of precision medicine in oncology will significantly contribute to the expansion of the global precision medicine market in the oncology segment during the forecast period. Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 - 2022) Research Analysis Precision medicine is a revolutionary approach to healthcare that takes into account the unique genetic, behavioral, and environmental variabilities of each individual to provide personalized treatment. This approach is particularly important in the context of illness susceptibility, as it can help identify those at higher risk for chronic diseases such as cancer, CNS disorders including Alzheimer's disease, epilepsy, and multiple sclerosis. The diagnosis and progression of these conditions can be influenced by various genetic and chromosomal abnormalities. High cost is a significant challenge in the precision medicine market, with the need for expensive genetic testing, prescription medicines, and companion diagnostics. Single nucleotide polymorphisms and genome sequencing are essential tools in precision medicine, enabling the identification of positive results for personalized therapeutics. Targeted gene therapy and personalized treatment drugs are key components of precision medicine, with reimbursement policies playing a crucial role in their commercialization. Prevalence of cancer and other chronic diseases continues to rise, making the need for precision medicine more urgent than ever. Despite these challenges, the potential benefits of this approach are significant, offering the promise of more effective and personalized healthcare solutions. Market Research Overview Precision Medicine Market refers to the emerging field of healthcare that utilizes genetic, environmental, and behavioral data to develop personalized treatment plans for diseases. This approach considers the unique variations in an individual's genetic makeup, chromosomal abnormalities, and molecular profiles to diagnose, treat, and prevent illnesses. Precision Medicine encompasses various applications, including cancer, chronic diseases, CNS disorders, and rare genetic disorders. Environmental variability and behavioral variability also play a role in illness susceptibility and disease progression. The Precision Medicine Market presents significant opportunities for personalized therapeutics and diagnostics. Genetic testing, microarray/biochips, and genome sequencing are crucial technologies in this arena. Companion diagnostics, calculation methodology, computational techniques, and targeted gene therapy are also essential components. Reimbursement policies, regulations, and healthcare infrastructure significantly impact the Precision Medicine Market. Price tags, funding programs, public healthcare systems, and healthcare access are key considerations. The biopharmaceutical arena, including Orchard Therapeutics, is commercializing personalized treatment choices based on positive results from genetic testing and molecular profiles. Regulations, guidelines, and policies from regulatory bodies influence the development and commercialization of precision medicine therapeutics. Conventional treatment methods, genomic research, and genetic targeted therapies continue to evolve in this rapidly advancing field. The Precision Medicine Market offers opportunities for biopharmaceutical players in oncology applications and therapeutic approaches for various diseases. The root cause of diseases can be identified through precision medicine, enabling a more effective therapeutic approach. Personalized medicine, wider adoption, and opportunities for treating rare genetic disorders and other rare diseases are significant market drivers. Developing regions are also exploring the potential of precision medicine to improve healthcare outcomes. Table of Contents: 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation Application Oncology CNS Respiratory Immunology Others Technology Bioinformatics Gene Sequencing Drug Discovery Precision Molecular Diagnostic Big Data Analytics Geography North America Europe Asia Rest Of World (ROW) 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: www.technavio.com/ SOURCE Technavio
It's been one month since the U.S. presidential election. And while Republicans and President-elect Donald Trump have been busy setting up a new White House administration, Democrats have spent the past four weeks trying to diagnose why they lost and how to move forward as a party. One person who thinks he has an answer to that is Ben Wikler, chairman of the Wisconsin Democratic Party. He's now running to become the new chairman of the national Democratic National Comittee because he says it's time to reassess what matters most to voters. RELATED STORY | DNC chair slams Bernie Sanders' criticism of Democratic Party "There's clearly a lot that we need to learn about what just happened, but one thing that jumps out is that a lot of voters who were taking it on the chin with high prices — frustrated by those prices — weren't hearing from either campaign and were voting for change," Wikler told Scripps News. "Well those voters, I think that we have a chance to reach out to them and say 'look, Democrats actually want to fight for an economy that works for working people and Trump wants to give multi-trillion tax cuts to billionaires at your expense. And that is a message we know can win because it's won downballot, it won in 2018, and it won in 2006 when George W. Bush tried to privatize social security." Meanwhile, the Supreme Court is currently hearing a potentially landmark case on gender affirming care for minors — which has been a big point for Democrats to campaign on. But a Scripps News/YouGov poll released early this year showed that more Americans support than oppose laws aimed at restricting transgender care for minors. RELATED STORY | Scripps News poll: Americans largely support restricting trans rights Wikler told Scripps News that if he were to be named chair of the DNC, it's a no-brainer that he'd support American's right to make their own private medical decisions without worrying about government intervention. "Republicans want to talk about trans issues and go on the attack against trans people because that is their way of trying to divide the public," he said. "People do disagree about this. Republicans want to focus on that disagreement and use attacks on trans people in order to distract folks from the big legislation that they are planning right now — which is a multi-trillion dollar tax cut for billionaires." "Democrats are always going to fight for people to have their basic personal freedom," Wikler continued. "And at the same time, we're going to fight against those who want to dismantle the federal government and the programs like social security and medicare and medicaid that people rely on for their their basic needs and health care." You can watch Scripps News' full interview with Ben Wikler in the video player above.TEHRAN – Iran's UN Ambassador Amir Saeed Iravani has dismissed U.S. and UK accusations of Iranian involvement in “regional destabilization” and the Ukraine conflict as unfounded. In a letter to the UN Security Council's rotating president, Barbara Woodward, Iravani rejected the allegations made during a November 18th Security Council meeting. “At this meeting, the U.S. representative, in collaboration with the Israeli regime, made an unconvincing effort to shift blame for their shared involvement in Israel's ongoing violent actions in Gaza and its war crimes in Lebanon by alleging that Iran is destabilizing the region to further its political interests. These claims against the Islamic Republic of Iran are firmly rejected,” his letter read. Iravani directly accused the U.S. and UK of hypocrisy, citing their unwavering support for Israel as the primary driver of regional instability and a direct contravention of the Security Council's mandate to maintain international peace and security. The diplomat emphasized Iran's consistent and unchanged position on the Ukraine conflict and further asserted that the U.S., through its support of Israel, bears direct responsibility for civilian casualties and destruction in Gaza, the West Bank, and Lebanon, enabled by U.S.-made weapons and the protection afforded by U.S. vetoes in the Security Council. “It is an indisputable reality that the loss of civilian lives, along with the destruction of infrastructure in Gaza and Lebanon, is occurring with American-made weapons and under the protection of the U.S. vetoes on ceasefire resolutions in the Security Council, which have shielded the Israeli regime from accountability,” the Iranian ambassador noted. He concluded by stating that the U.S. and UK cannot evade accountability for their role in perpetuating these conflicts. “The United States and Britain cannot evade accountability while facilitating the actions of the Israeli regime. Their unwavering support for Israel perpetuates ongoing conflicts and undermines the Security Council’s efforts to uphold international peace and security.”Democrat Bob Casey concedes to Republican David McCormick in Pennsylvania Senate contest
TEL AVIV, Israel (AP) — Israeli Prime Minister Benjamin Netanyahu underwent successful surgery Sunday to have his prostate removed, hospital officials said, a procedure that came as he manages multiple crises including the war in Gaza and his trial for alleged corruption . Netanyahu, who has had a series of health issues in recent years, has gone to great lengths to bolster a public image of himself as a healthy, energetic leader. During his trial this month, he boasted about working 18-hour days, accompanied by a cigar. But as Israel's longest-serving leader, such a grueling workload over a total of 17 years in power could take a toll on his well-being. Netanyahu, 75, is among older world leaders including U.S. President Joe Biden, 82 , President-elect Donald Trump, 78 , Brazil's President Luiz Inácio Lula da Silva , 79, and Pope Francis , 88, who have come under scrutiny for their age and health issues. Netanyahu's latest condition is common in older men, but the procedure has had some fallout. The judges overseeing his trial accepted a request from his lawyer on Sunday to call off three days of testimony scheduled this week. The lawyer, Amit Hadad, had argued that Netanyahu would be fully sedated for the procedure and hospitalized for “a number of days.” Jerusalem's Hadassah Medical Center announced late Sunday that the procedure had been completed successfully and that the prime minister had woken up. Netanyahu thanked his doctors. His office said he was "fully alert" and was taken to an underground recovery unit fortified against potential missile attacks. Netanyahu was expected to remain in the hospital for several days of observation. Justice Minister Yariv Levin, a close ally, served as acting prime minister during the operation. With so much at stake, Netanyahu’s health in wartime is a concern for both Israelis and the wider world. As Israel’s leader, Netanyahu is at the center of major global events that are shifting the Middle East . With the dizzying pace of the past 14 months, being incapacitated for even a few hours can be risky. Netanyahu will be in the hospital at a time when international mediators are pushing Israel and Hamas to reach a ceasefire in Gaza and as fighting between Israel and Yemen’s Iran-backed Houthi rebels intensifies . Prostate issues are common and in many cases easily treatable. Still, the procedure puts a dent in Netanyahu’s image of vigor at a time when he would want to project strength more than ever, both to an Israeli audience navigating constant threats as well as to Israel’s enemies looking to expose its weaknesses. Netanyahu insists he is in excellent health. His office releases footage of him touring war zones in full protective gear flanked by military officers, or meeting with defense officials on windswept hilltops in youthful dark shades and puffer jackets. But that image was shattered last year when Netanyahu’s doctors revealed that he had a heart condition , a problem that he had apparently long known about but concealed from the public. A week after a fainting spell, Netanyahu was fitted with a pacemaker to control his heartbeat. Only then did staff at the Sheba Medical Center reveal that Netanyahu has for years experienced a condition that can cause irregular heartbeats. The revelation came as Netanyahu was dealing with massive anti-government protests. The news about a chronic heart problem stoked further anger and distrust during extreme political polarization in Israel. Last year, Netanyahu was rushed to the hospital for what doctors said likely was dehydration . He stayed overnight, prompting his weekly Cabinet meeting to be delayed. Earlier this year, Netanyahu underwent hernia surgery , during which he was under full anesthesia and unconscious. Levin served as acting prime minister during the operation. According to Netanyahu’s office, the Israeli leader was diagnosed with a urinary tract infection on Wednesday stemming from a benign enlargement of his prostate. The infection was treated successfully with antibiotics, but doctors said the surgery was needed in any case. Complications from prostate enlargement are common in men in their 70s and 80s, Dr. Shay Golan, head of the oncology urology service at Israel’s Rabin Medical Center, told Israeli Army Radio. Golan spoke in general terms and was not involved in Netanyahu’s care or treatment. He said an enlarged prostate can block proper emptying of the bladder, leading to a build-up of urine that can lead to an infection or other complications. After medicinal treatment, doctors can recommend a procedure to remove the prostate to prevent future blockages, Golan said. In Netanyahu’s case, because the prostate is not cancerous, Golan said doctors were likely performing an endoscopic surgery, carried out by inserting small instruments into a body cavity, rather than making surgical cuts in the abdomen to reach the prostate. The procedure lasts about an hour, Golan said, and recovery is quick. He said that aside from catheter use for one to three days after the procedure, patients can return to normal activity without significant limitations. AP correspondent Isaac Scharf contributed reporting.
‘World at dawn of third nuclear age’, armed forces chief warnsThe team that President-elect has selected to lead federal health agencies in his second administration includes a retired congressman, a surgeon and a former talk-show host. All could play pivotal roles in fulfilling a political agenda that could change how the government goes about safeguarding Americans’ health — from health care and medicines to food safety and science research. In line to lead the Department of Health and Human Services secretary is environmental lawyer and anti-vaccine organizer Trump’s choices don’t have experience running large bureaucratic agencies, but they . Centers for Medicare and Medicaid pick Dr. hosted a talk show for 13 years and is a well-known wellness and lifestyle influencer. The pick for the Food and Drug Administration, Dr. and for surgeon general, Dr. Janette Nesheiwat, are frequent Fox News contributors. Many on the list were critical of COVID-19 measures like masking and booster vaccinations for young people. Some of them have ties to Florida like many of Trump’s other Cabinet nominees: , the pick for the Centers for Disease Control and Prevention, represented the state in Congress for 14 years and is affiliated with a medical group on the state’s Atlantic coast. Nesheiwat’s brother-in-law is , R-Fla., tapped by Trump as national security adviser. Here’s a look at the nominees’ potential role in carrying out what Kennedy says is the task to “reorganize” agencies, which have an overall $1.7 billion budget, employ 80,000 scientists, researchers, doctors and other officials, and effect Americans’ daily lives: Centers for Disease Control and Prevention The Atlanta-based CDC, with a $9.2 billion core budget, is charged with protecting Americans from disease outbreaks and other public health threats. Kennedy has long attacked vaccines and criticized the CDC, repeatedly alleging corruption at the agency. He said on a 2023 podcast that there is “no vaccine that is safe and effective,” and urged people to resist . Decades ago, Kennedy found common ground with , 71, who served in the Army and worked as an internal medicine doctor before he represented a central Florida congressional district from 1995 to 2009. Starting in the early 2000s, Weldon had a prominent part in a debate about whether there was a relationship between a vaccine preservative called thimerosal and autism. He was a founding member of the Congressional Autism Caucus and tried to ban thimerosal from all vaccines. Kennedy, then a senior attorney for the Natural Resources Defense Council, believed there was a tie between thimerosal and autism and also charged that the government hid documents showing the danger. Since 2001, all vaccines manufactured for the U.S. market and routinely recommended for children 6 years or younger have contained no thimerosal or only trace amounts, with the exception of inactivated influenza vaccine. Meanwhile, study after study after study found no evidence that thimerosal caused autism. Weldon’s congressional voting record suggests he may go along with Republican efforts to downsize the CDC, including to eliminate the National Center for Injury Prevention and Control, which works on topics like drownings, drug overdoses and shooting deaths. Weldon also voted to ban federal funding for needle-exchange programs as an approach to reduce overdoses, and the National Rifle Association gave him an “A” rating for his pro-gun rights voting record. Food and Drug Administration Kennedy is extremely critical of the FDA, which has 18,000 employees and is responsible for the safety and effectiveness of prescription drugs, vaccines and other medical products, as well as overseeing cosmetics, electronic cigarettes and most foods. Makary, Trump’s pick to run the FDA, is closely aligned with Kennedy on . The professor at Johns Hopkins University who is a trained surgeon and cancer specialist has decried the overprescribing of drugs, the use of pesticides on foods and the undue influence of pharmaceutical and insurance companies over doctors and government regulators. Kennedy has suggested he’ll clear our “entire” FDA departments and also recently threatened to fire FDA employees for “aggressive suppression” of a host of unsubstantiated products and therapies, including stem cells, , and like ivermectin and hydroxychloroquine. Makary’s contrarian views during the COVID-19 pandemic included questioning the need for masking and giving young kids COVID-19 vaccine boosters. But anything Makary and Kennedy might want to do when it comes to unwinding FDA regulations or revoking long-standing vaccine and drug approvals would be challenging. The agency has lengthy requirements for removing medicines from the market, which are based on federal laws passed by Congress. Centers for Medicaid and Medicare Services The agency provides health care coverage for more than 160 million people through Medicaid, Medicare and the Affordable Care Act, and also sets Medicare payment rates for hospitals, doctors and other providers. With a $1.1 trillion budget and more than 6,000 employees, Oz has a massive agency to run if confirmed — and an agency that Kennedy hasn’t talked about much when it comes to his plans. While Trump tried to scrap the Affordable Care Act in his first term, Kennedy has not taken aim at it yet. But he has been critical of Medicaid and Medicare for covering expensive weight-loss drugs — though . Trump said that he would protect Medicare, which provides insurance for older Americans. has endorsed expanding Medicare Advantage — a privately run version of Medicare that is popular — in during his failed 2022 bid for a U.S. Senate seat in Pennsylvania and in a with a former Kaiser Permanente CEO. Oz also said in a Washington Examiner with three co-writers that aging healthier and living longer could help fix the U.S. budget deficit because people would work longer and add more to the gross domestic product. Neither Trump nor Kennedy have said much about Medicaid, the insurance program for low-income Americans. Trump’s first administration reshaped the program by allowing states to introduce work requirements for recipients. Surgeon general Kennedy doesn’t appear to have said much publicly about what he’d like to see from surgeon general position, which is the nation’s top doctor and oversees 6,000 U.S. Public Health Service Corps members. The surgeon general has little administrative power, but can be an influential government spokesperson on what counts as a public health danger and what to do about it — suggesting things like warning labels for products and issuing advisories. The current surgeon general, Vivek Murthy, in June. Trump’s pick, Nesheiwat, is employed as a New York City medical director with CityMD, a group of urgent care facilities in the New York and New Jersey area, and has been at City MD for 12 years. She also has appeared on Fox News and other TV shows, authored a book on the “transformative power of prayer” in her medical career and endorses a brand of vitamin supplements. She encouraged COVID-19 vaccines during the pandemic, calling them “a gift from God” in a February 2021 Fox News op-ed, as well as anti-viral pills like Paxlovid. In a 2019 Q&A with the , Nesheiwat said she is a “firm believer in preventive medicine” and “can give a dissertation on hand-washing alone.” National Institutes of Health As of Saturday, Trump had not yet named his choice to lead the National Institutes of Health, which funds medical research through grants to researchers across the nation and conducts its own research. It has a $48 billion budget. Kennedy has said he’d drug development and infectious disease research to shift the focus to chronic diseases. He’d like to keep NIH funding from researchers with conflicts of interest, and criticized the agency in 2017 for what he said was not doing enough research into the role of vaccines in autism — . ___ Associated Press writers Amanda Seitz and Matt Perrone and AP editor Erica Hunzinger contributed to this report. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Mike Stobbe, The Associated PressTEHRAN – Iran's UN Ambassador Amir Saeed Iravani has dismissed U.S. and UK accusations of Iranian involvement in “regional destabilization” and the Ukraine conflict as unfounded. In a letter to the UN Security Council's rotating president, Barbara Woodward, Iravani rejected the allegations made during a November 18th Security Council meeting. “At this meeting, the U.S. representative, in collaboration with the Israeli regime, made an unconvincing effort to shift blame for their shared involvement in Israel's ongoing violent actions in Gaza and its war crimes in Lebanon by alleging that Iran is destabilizing the region to further its political interests. These claims against the Islamic Republic of Iran are firmly rejected,” his letter read. Iravani directly accused the U.S. and UK of hypocrisy, citing their unwavering support for Israel as the primary driver of regional instability and a direct contravention of the Security Council's mandate to maintain international peace and security. The diplomat emphasized Iran's consistent and unchanged position on the Ukraine conflict and further asserted that the U.S., through its support of Israel, bears direct responsibility for civilian casualties and destruction in Gaza, the West Bank, and Lebanon, enabled by U.S.-made weapons and the protection afforded by U.S. vetoes in the Security Council. “It is an indisputable reality that the loss of civilian lives, along with the destruction of infrastructure in Gaza and Lebanon, is occurring with American-made weapons and under the protection of the U.S. vetoes on ceasefire resolutions in the Security Council, which have shielded the Israeli regime from accountability,” the Iranian ambassador noted. He concluded by stating that the U.S. and UK cannot evade accountability for their role in perpetuating these conflicts. “The United States and Britain cannot evade accountability while facilitating the actions of the Israeli regime. Their unwavering support for Israel perpetuates ongoing conflicts and undermines the Security Council’s efforts to uphold international peace and security.”
Promising young Kiwisnowboarders Keani Wilson (17) and Brooke Hansen (17), anddownhill mountain bikers Quinn Ravenwood (13) and IndyDeavoll (16), all based in Queenstown, are the firstteenagers to be selected for the RISER programme, a uniquesponsorship partnership with tourism pioneers AJ HackettBungy New Zealand (AJHBNZ). The new programme aims tohelp young athletes competing at the highest level byopening the door to access important resources, such asperformance development, social media training and financialsupport – skills needed to springboard the athletes’existing talents towards a potential elite career andprepare them for international sponsorshipopportunities. “We have been wanting to dothis for years after receiving a lot of requests forsponsorship from athletes, nationally andinternationally,” he says. “We’re excited toofficially launch RISER and have Quinn, Brooke, Keani andIndy as the first ambassadors. They truly embody our ‘livemore, fear less’ mantra and are already on the road tobecoming some of NZ’s promising sportingtalent. “For me, this programme feels like it’scoming full circle,” van Asch explains. “In my twenties,I represented New Zealand in European Speed Skiing andcompeted internationally in downhill mountain biking, so Iunderstand the challenges aspiring high-performance athletesencounter. “We believe it’s important to supportyoung Kiwis on their journey to achieving excellence intheir respective disciplines, with the overall goal ofhelping them to be noticed by global brands. If we can helpour RISER athletes to get noticed by big players like RedBull, for example, then we have done a goodjob.” Young Kiwi athletes that are competing in anyaction sport discipline at the highest level nationally orinternationally, with aspirations of taking their sport tothe elite level, are eligible to apply for the annual RISERsponsorship programme. RISER athletes will receive apersonalised gear kit, containing branded apparel – ahoodie, t-shirt, cap – a bespoke helmet, as well as somefinancial support to assist with competition costs. Otherwraparound support such as mindset coaching is currentlybeing developed. Mountain bike athletes will receive elitesupport from Queenstown-based Onward MTBCoaching. Additionally, the athletes will have accessto a digital marketing coach – focusing on enhancing theathletes’ online profiles to improve the chances of beingnoticed by international brands – as well as ongoingeducation about professional sponsorships. AthleteIndy Deavoll says she’s stoked about the opportunity to bepart of the first intake of RISER athletes. “Thesupport this programme gives me, in the way of coaching andtravel costs, will really help to grow me as an athlete,”she says. “I think it's really cool that this localQueenstown business is giving back to the communityandhelping young athletes." More information about thefour RISER athletes:
Houston Child Custody Lawyer Whitney L. Thompson Releases Comprehensive Article on Texas Child Custody Laws 12-04-2024 10:34 PM CET | Politics, Law & Society Press release from: ABNewswire Houston child custody lawyer [ https://www.wthompsonlaw.com/child-custody/ ] Whitney L. Thompson of The Law Office of Whitney L. Thompson, PLLC, has released an insightful article detailing the nuances of child custody laws in Texas. The article serves as a valuable resource for parents, guardians, and other family members involved in the often emotional and complex process of child custody. In her article, Houston child custody lawyer Thompson highlights the challenges faced by parents, grandparents, or other family members who step into custody disputes. Whether it involves a divorcing couple, single parents, or complex family dynamics, the article underscores the importance of understanding the legal framework surrounding child custody in Texas. "Child custody cases can be overwhelming, especially when emotions run high," Houston child custody lawyer Whitney L. Thompson explains. "It's important for families to know their legal rights and options in order to make decisions that truly benefit the child." Whitney L. Thompson explores the two primary types of conservatorship recognized by Texas law: joint managing conservatorship and sole managing conservatorship. She explains that the state typically presumes joint custody to be in the best interest of the child, allowing both parents to share decision-making responsibilities. However, certain circumstances, such as abuse, neglect, or abandonment, can lead to sole custody being awarded to one parent. "Texas courts prioritize the best interest of the child above all else," Thompson writes. "This principle guides every decision, from assigning parental rights and duties to determining visitation schedules. Parents need to prepare thoroughly and present their case effectively to demonstrate what arrangement will best serve their child's welfare." The article provides a detailed breakdown of key legal concepts, including the terminology used in Texas custody cases. In Texas, "custody" is referred to as "conservatorship," and parents can be named as joint managing conservators or sole managing conservators. Thompson clarifies that while Texas law favors joint custody, the court may adjust or deny this presumption if evidence shows that joint custody would not be in the child's best interest. Thompson also touches on the modification of custody orders, a topic that resonates with many parents whose circumstances change over time. She notes that courts require a substantial change in circumstances or a child's expressed preferences (for children over 12 years old) before modifying custody arrangements. One of the most enlightening aspects of the article is its discussion of gender neutrality in Texas custody cases. Historically, courts leaned toward awarding custody to mothers, especially of younger children, under the "tender years doctrine." However, Thompson outlines how Texas law has evolved to ensure custody decisions are made without regard to gender. "Both mothers and fathers are treated equally in Texas courts," Thompson says. "The focus is solely on the child's needs and which parent is best suited to meet them." In addition to explaining the legal landscape, Thompson offers practical advice for parents involved in custody disputes. She encourages parents to document their involvement in their child's life, maintain a stable home environment, and create a detailed parenting plan that addresses key aspects such as education, healthcare, and visitation schedules. For fathers, who may feel at a disadvantage due to lingering societal stereotypes, the article provides specific tips on how to present a strong case for custody. This includes compiling evidence of active parenting, organizing financial records, and demonstrating a commitment to the child's well-being. "Preparation is key," Thompson states. "Parents who come to court with a clear plan and evidence of their involvement in their child's life can significantly strengthen their case." For those facing child custody challenges in Houston, the article underscores the critical importance of understanding the law and seeking the right legal guidance. Custody disputes can be emotionally taxing, but they can also shape a child's future. Thompson encourages parents and guardians to educate themselves, communicate effectively, and, when necessary, enlist the help of a qualified child custody attorney to guide them through the process. About The Law Office of Whitney L. Thompson, PLLC: The Law Office of Whitney L. Thompson, PLLC, is a Houston-based family law firm dedicated to helping families address challenging legal issues with compassion and professionalism. Led by Whitney L. Thompson, the firm handles a wide range of family law matters, including child custody and divorce. Committed to advocating for the best interests of children and families, the firm provides personalized legal solutions tailored to each client's unique situation. Embeds: Youtube Video: https://www.youtube.com/watch?v=Kksnegx_2Dw GMB: https://www.google.com/maps?cid=9428708165305469162 Email and website Email: info@wthompsonlaw.com Website: https://www.wthompsonlaw.com/ Media Contact Company Name: The Law Office of Whitney L. Thompson, PLLC Contact Person: Whitney L. Thompson Email:Send Email [ https://www.abnewswire.com/email_contact_us.php?pr=houston-child-custody-lawyer-whitney-l-thompson-releases-comprehensive-article-on-texas-child-custody-laws ] Phone: (281) 214-0173 Address:4201 Farm to Market 1960 Rd W Suite 360 City: Houston State: Texas 77068 Country: United States Website: https://www.wthompsonlaw.com/ This release was published on openPR.Zero Zero Robotics showcases bestselling HOVERAir X1 series at CES 2025
Donald Trump says he urged Gretzky to run for prime minister in Christmas visit
Daily Post Nigeria 16 Days of Activism: Ogun commits to safety for women, girls Home News Politics Metro Entertainment Sport News 16 Days of Activism: Ogun commits to safety for women, girls Published on December 4, 2024 By Timi Owolabi To reduce the menace of Gender-Based Violence, GBV, the Ogun State Commissioner for Women Affairs and Social Development, Adijat Adeleye, has called for action to raise voices for and make commitments to the safety of women and girls. Adeleye made this call at a town hall meeting in partnership with the United Nations Population Fund, UNFPA, community and other opinion leaders on prevention and response to GBV held in Abeokuta on Wednesday. She said the meeting was in commemoration of the 16 Days Activism on the elimination of all forms of violence against the female gender, stating that community leaders comprising Baales, religious leaders, and Community Development Association leaders, among others, were gatekeepers of the community. The commissioner emphasised that they exhibit a significant role in shaping minds, influencing behaviours and building trust, charging them to look beyond ongoing campaigns to make a lasting impact in the fight against GBV in their respective communities. “We need to implement these plans; action they say is key. This is not a checklist we can tick and move on. It’s a breathing process and it starts with you. You have to walk the talk. So, when we create action plans, ensure they don’t collect dust on some shelf. Make sure they are enforced; talk about it in your communities, churches, mosques, garages and parks, and share from one leader to another,” she said. While reeling out the strides of the Abiodun-led administration in ridding the state of GBV, the commissioner stated that the government had established Sexual Assault Referral Centres, SARC, in zones of the state in collaboration with the United Nations Population Fund, UNFPA, and Ogun State Transformation Projects, OGSTEP. The centres, she added, were equipped to provide immediate care, support and counselling for survivors of GBV. She added that this intervention aimed to facilitate the commencement of the healing process for survivors, revealing that toll-free lines had equally been provided for a quick response from the government-trained responders and service providers. In her welcome address, the Permanent Secretary in the ministry, Adejumoke Adewole, underscored the importance of a collective mission to raise awareness of GBV and advocate for the rights and dignity of women and girls in communities. She implored the stakeholders to use their positions to speak on behalf of the voiceless, particularly women and girls, calling on them to work together with the state government and UNFPA to curb structures perpetuating violence in society. Earlier in her lecture titled “Roles of Community Leaders in Responding and Preventing GBV,” UNFPA’s gender analyst, Dr Esther Somefun, highlighted some of the key roles of community leaders as embracing and encouraging survivors of GBV, avoiding discrimination towards them, reporting acts of violence against women and girls at all times and publicising the toll-free lines for reporting GBV. While delivering another lecture, a representative of APIN Public Health Initiatives, Favour Ojo-Omoniyi, noted that opinion leaders needed to equip themselves with necessary education about GBV and prepare to offer support to survivors. Representative of the Forum of Muslim Women Association of Nigeria, FOMWAN, Zainab Jinadu and her counterpart from the National Union of Road Transport Workers, NURTW, Osioyemi Olasunkanmi, commended the state government and UNFPA for coming up with the idea of involving them as gatekeepers of the community in eliminating GBV cases. Related Topics: 16 Days of Activism ogun Don't Miss Tax reforms crucial for national growth — NOA You may like Abiodun presents N1.055tn 2025 budget to Ogun Assembly Ogun pledges to break down societal stereotypes, provide job opportunities for PWDs Police confirm suspected assassination of hotel guest in Ogun Teacher attempts suicide as Ogun pupil loses eye to classroom accident Man slumps, dies while walking on Ogun road Why I consistently focus on development of Ogun West – Gov. Abiodun Advertise About Us Contact Us Privacy-Policy Terms Copyright © Daily Post Media LtdSoutheastern Grocers gives customers extra jingle in their pockets with over $50,000 in free groceries